As the field moves toward integrative disease models and precision medicine, neuroendocrine and immunemetabolic peptides may represent a critical frontier for therapeutic innovation
Amid growing concerns about cost, side effects, and long-term use, the survey suggests that awareness of GLP-1s has not necessarily translated into widespread acceptance
Frequently Asked Questions Why is traditional fiber bad for GLP-1 constipation
Ayotte said Wednesday she would not reconsider the decision
The Medicare GLP-1 Bridge is a nationwide demonstration program that will be separate from Part D coverage, meaning Part D sponsors will not have to opt into the demonstration for eligible beneficiaries to gain access, nor will Part D sponsors bear any financial risk for costs incurred by their enrollees associated with the demonstration
As of April 2025, the FDA received over 1,000 adverse event reports related to compounded semaglutide and tirzepatide